Swiss-US Trade / Why an FTA Would Prevent Switzerland from ‘Falling Through the Cracks’
The USA is now Switzerland’s biggest export market and in 2019 Switzerland exported more to the US than to…
AMERICAS
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
Data / Canada Pharma Snapshot 2020
Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics,…
USA / This Could Get Messy: Trump’s New ‘Most Favoured Nation’ Executive Order on Medicine Pricing
Regular PharmaBoardroom contributor Brendan Shaw weighs in on the potential implications for US pharma of President…
USA / 3 Pharma Mid-Cap Execs to Know
The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish…
Mexico / Indian Investment to Bolster Domestic Supply Chain post-COVID
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in…
Cancer in the USA: A Snapshot
In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments.…
Brazil / Top 5 Pharma Companies
Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…
Alzheimer's / Aducanumab: On the Regulatory Home Stretch in the USA
In the third of a series of articles chronicling Biogen/Eisai’s Alzheimer’s Disease (AD) treatment…
In Conversation
Tatsuya Kaihara – Corporate Officer, Head of North America Business, Santen Pharmaceutical Co., Ltd. & CEO, Santen Inc.
Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his excitement at bringing two new ophthalmic advancements to the US market, the similarities, differences, and synergies of Japanese and American innovation, and the challenges of building a unified corporate culture. This is a very exciting moment for the Santen US affiliate Tatsuya, you were appointed president…
Latest Reports
Focus on Colombia
Colombian Tecnoquimicas’ USD 200 Million Manufacturing…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion…
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Read more from Colombia >>
Focus on Puerto Rico
New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after…
Company Spotlight: Puerto Rico’s Quality &…
When life sciences companies decide to transfer the production of new drug to…
Read more from Puerto Rico >>
Focus on Brazil
Top 5 Brazilian Pharma Companies
Six of the top ten companies in the Brazilian pharma market are domestic.* Read…
Six Trends in the Brazilian OTC Market Post-COVID-19
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19…
Read more from Brazil >>
Focus on Mexico
Mexico Looks to India to Bolster Domestic Supply Chain…
COVID-19 has highlighted the importance of secure regional pharma supply chains…
Pharma Faces: Constanza Losada, Pfizer Mexico
Pfizer, one of the world’s largest pharmaceutical companies, has been active…
Read more from Mexico >>
Focus on Canada
The Evolution of Medical Cannabis Legislation in Canada
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical…
Has the Time Truly Come for Trudeau’s ‘National…
As the only country in the world to boast a universal healthcare system that…
Read more from Canada >>
Focus on USA
Takeda USA’s Ramona Sequeira Talks “Culture as…
After five years with Takeda heading up the Japan-headquartered pharma…
Is the USA’s Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides…
Read more from USA >>
USA / 3 Pharma Mid-Cap Execs to Know
The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish…
Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial…
Pharma Faces / Jorge Rodríguez, PACIV, Puerto Rico
Over the last 22 years, Jorge Rodríguez has grown Puerto Rican industrial automation solutions provider PACIV from…
Pricing / Drugmakers Push Back Against Canada's New Regulations
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory…
Talent / Mexican Pharma: Where Are They Now?
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and…
LatAm / What Can Brazil’s Pharma Industry Learn from India?
The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to…